| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 2.81 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, AlphaFold 3 column; Table 1 assessable count |
|---|
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.84 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, AlphaFold 3 column; Table 1 assessable count |
|---|
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 6.56 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, AlphaFold 3 column; Table 1 assessable count |
|---|
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 83% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, AlphaFold 3 column; Table 1 assessable count |
|---|
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 2.88 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, Boltz-1 column; Table 1 assessable count |
|---|
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.83 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, Boltz-1 column; Table 1 assessable count |
|---|
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 8.82 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, Boltz-1 column; Table 1 assessable count |
|---|
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 79.2% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, Boltz-1 column; Table 1 assessable count |
|---|
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 3.36 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, Chai-1 column; Table 1 assessable count |
|---|
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.82 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, Chai-1 column; Table 1 assessable count |
|---|
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 8.77 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, Chai-1 column; Table 1 assessable count |
|---|
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 66.7% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, Chai-1 column; Table 1 assessable count |
|---|
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 3.72 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, HelixFold 3 column; Table 1 assessable count |
|---|
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.83 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, HelixFold 3 column; Table 1 assessable count |
|---|
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 9.79 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, HelixFold 3 column; Table 1 assessable count |
|---|
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 89.5% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, HelixFold 3 column; Table 1 assessable count |
|---|
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 2.93 CAPRI interface RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, iRMSD row, Protenix column; Table 1 assessable count |
|---|
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 0.83 lDDT fraction · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, LDDT row, Protenix column; Table 1 assessable count |
|---|
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 8.44 CAPRI ligand RMSD angstrom · lower Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, lRMSD row, Protenix column; Table 1 assessable count |
|---|
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench protein-peptide published full-set assessment Dataset: FoldBench protein-peptide published targets | 77.1% FoldBench success rate percent · higher Uncertainty: Not yet extracted Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench protein peptide protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, protein-peptide block, Success rate row, Protenix column; Table 1 assessable count |
|---|